[(radical surgical approaches,is in,breast cancer,1.0), (prolonged recovery,delay of,radiotherapy,1.0), (BACKGROUND,remains Despite,trend for less radical surgical approaches in breast cancer due better understanding of tumour biology,1.0)][(radical surgical approaches,is in,breast cancer,1.0), (prolonged recovery,delay of,radiotherapy,1.0), (BACKGROUND,remains Despite,trend for less radical surgical approaches in breast cancer due better understanding of tumour biology,1.0)][(radical surgical approaches,is in,breast cancer,1.0), (prolonged recovery,delay of,radiotherapy,1.0), (BACKGROUND,remains Despite,trend for less radical surgical approaches in breast cancer due better understanding of tumour biology,1.0)][(aim,provide,update,1.0), (aim,provide,update on risk factors for seroma production after breast cancer surgery,1.0), (update,considering,treatment options,1.0), (aim,provide,update on risk factors,1.0), (aim,provide,update on risk factors for seroma production,1.0), (update,considering,latest treatment options,1.0)][(aim,provide,update,1.0), (aim,provide,update on risk factors for seroma production after breast cancer surgery,1.0), (update,considering,treatment options,1.0), (aim,provide,update on risk factors,1.0), (aim,provide,update on risk factors for seroma production,1.0), (update,considering,latest treatment options,1.0)][(aim,provide,update,1.0), (aim,provide,update on risk factors for seroma production after breast cancer surgery,1.0), (update,considering,treatment options,1.0), (aim,provide,update on risk factors,1.0), (aim,provide,update on risk factors for seroma production,1.0), (update,considering,latest treatment options,1.0)][(aim,provide,update,1.0), (aim,provide,update on risk factors for seroma production after breast cancer surgery,1.0), (update,considering,treatment options,1.0), (aim,provide,update on risk factors,1.0), (aim,provide,update on risk factors for seroma production,1.0), (update,considering,latest treatment options,1.0)][(aim,provide,update,1.0), (aim,provide,update on risk factors for seroma production after breast cancer surgery,1.0), (update,considering,treatment options,1.0), (aim,provide,update on risk factors,1.0), (aim,provide,update on risk factors for seroma production,1.0), (update,considering,latest treatment options,1.0)][(aim,provide,update,1.0), (aim,provide,update on risk factors for seroma production after breast cancer surgery,1.0), (update,considering,treatment options,1.0), (aim,provide,update on risk factors,1.0), (aim,provide,update on risk factors for seroma production,1.0), (update,considering,latest treatment options,1.0)][(seroma production,is in,primary breast cancer patients treated between 01.01.2010,1.0), (analysis,was,performed,0.6952661858214036), (retrospective analysis,was,performed,0.6952661858214036)][(seroma production,is in,primary breast cancer patients treated between 01.01.2010,1.0), (analysis,was,performed,0.6952661858214036), (retrospective analysis,was,performed,0.6952661858214036)][(seroma production,is in,primary breast cancer patients treated between 01.01.2010,1.0), (analysis,was,performed,0.6952661858214036), (retrospective analysis,was,performed,0.6952661858214036)][(Patients,is with,previous breast/axillary surgery,1.0)][(Seroma formation,using,wound drains,1.0), (Seroma formation,using,wound drains placed,1.0), (Seroma formation,using,wound drains placed in breast,1.0), (Seroma formation,was,measured,1.0)][(Seroma formation,using,wound drains,1.0), (Seroma formation,using,wound drains placed,1.0), (Seroma formation,using,wound drains placed in breast,1.0), (Seroma formation,was,measured,1.0)][(Seroma formation,using,wound drains,1.0), (Seroma formation,using,wound drains placed,1.0), (Seroma formation,using,wound drains placed in breast,1.0), (Seroma formation,was,measured,1.0)][(Seroma formation,using,wound drains,1.0), (Seroma formation,using,wound drains placed,1.0), (Seroma formation,using,wound drains placed in breast,1.0), (Seroma formation,was,measured,1.0)][(RESULTS,met In,total,1.0), (581 patients,met inclusion criteria In,total,0.8263367537373778), (patients,met,inclusion criteria,0.8263367537373778), (581 patients,met,inclusion criteria,0.8263367537373778), (patients,met inclusion criteria In,total,0.8263367537373778)][(RESULTS,met In,total,1.0), (581 patients,met inclusion criteria In,total,0.8263367537373778), (patients,met,inclusion criteria,0.8263367537373778), (581 patients,met,inclusion criteria,0.8263367537373778), (patients,met inclusion criteria In,total,0.8263367537373778)][(RESULTS,met In,total,1.0), (581 patients,met inclusion criteria In,total,0.8263367537373778), (patients,met,inclusion criteria,0.8263367537373778), (581 patients,met,inclusion criteria,0.8263367537373778), (patients,met inclusion criteria In,total,0.8263367537373778)][(RESULTS,met In,total,1.0), (581 patients,met inclusion criteria In,total,0.8263367537373778), (patients,met,inclusion criteria,0.8263367537373778), (581 patients,met,inclusion criteria,0.8263367537373778), (patients,met inclusion criteria In,total,0.8263367537373778)][(RESULTS,met In,total,1.0), (581 patients,met inclusion criteria In,total,0.8263367537373778), (patients,met,inclusion criteria,0.8263367537373778), (581 patients,met,inclusion criteria,0.8263367537373778), (patients,met inclusion criteria In,total,0.8263367537373778)][(age,was,60 years,1.0), (Median age,was,60 years,1.0)][(age,was,60 years,1.0), (Median age,was,60 years,1.0)][(patients,received,IORT,1.0), (patients,received,NAC,1.0)][(patients,received,IORT,1.0), (patients,received,NAC,1.0)][(amount,was,82.5 ml,1.0), (seroma production,Median amount of was,82.5 ml,1.0), (seroma production,amount of was,82.5 ml,1.0), (Median amount,was,82.5 ml,1.0)][(amount,was,82.5 ml,1.0), (seroma production,Median amount of was,82.5 ml,1.0), (seroma production,amount of was,82.5 ml,1.0), (Median amount,was,82.5 ml,1.0)][(amount,was,82.5 ml,1.0), (seroma production,Median amount of was,82.5 ml,1.0), (seroma production,amount of was,82.5 ml,1.0), (Median amount,was,82.5 ml,1.0)][(amount,was,82.5 ml,1.0), (seroma production,Median amount of was,82.5 ml,1.0), (seroma production,amount of was,82.5 ml,1.0), (Median amount,was,82.5 ml,1.0)][(most,was,due,1.0), (observed variation,is in,seroma production,1.0), (most,was due to,type of surgery,1.0), (most,was due to,type,1.0)][(most,was,due,1.0), (observed variation,is in,seroma production,1.0), (most,was due to,type of surgery,1.0), (most,was due to,type,1.0)][(most,was,due,1.0), (observed variation,is in,seroma production,1.0), (most,was due to,type of surgery,1.0), (most,was due to,type,1.0)][(most,was,due,1.0), (observed variation,is in,seroma production,1.0), (most,was due to,type of surgery,1.0), (most,was due to,type,1.0)][(IORT,explained,amount of variation in seroma production,1.0), (IORT,explained,amount of observed variation in seroma production,1.0), (IORT,explained,amount of variation,1.0), (observed variation,is in,seroma production,1.0), (IORT,explained,amount of observed variation,1.0), (IORT,explained,amount,1.0)][(IORT,explained,amount of variation in seroma production,1.0), (IORT,explained,amount of observed variation in seroma production,1.0), (IORT,explained,amount of variation,1.0), (observed variation,is in,seroma production,1.0), (IORT,explained,amount of observed variation,1.0), (IORT,explained,amount,1.0)][(IORT,explained,amount of variation in seroma production,1.0), (IORT,explained,amount of observed variation in seroma production,1.0), (IORT,explained,amount of variation,1.0), (observed variation,is in,seroma production,1.0), (IORT,explained,amount of observed variation,1.0), (IORT,explained,amount,1.0)][(IORT,explained,amount of variation in seroma production,1.0), (IORT,explained,amount of observed variation in seroma production,1.0), (IORT,explained,amount of variation,1.0), (observed variation,is in,seroma production,1.0), (IORT,explained,amount of observed variation,1.0), (IORT,explained,amount,1.0)][(IORT,explained,amount of variation in seroma production,1.0), (IORT,explained,amount of observed variation in seroma production,1.0), (IORT,explained,amount of variation,1.0), (observed variation,is in,seroma production,1.0), (IORT,explained,amount of observed variation,1.0), (IORT,explained,amount,1.0)][(IORT,explained,amount of variation in seroma production,1.0), (IORT,explained,amount of observed variation in seroma production,1.0), (IORT,explained,amount of variation,1.0), (observed variation,is in,seroma production,1.0), (IORT,explained,amount of observed variation,1.0), (IORT,explained,amount,1.0)]